Back to Articles
45072026 Q3PrimeIFRS

Shionogi & (4507) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥360.7B (+8.1% year on year) and operating income ¥148.7B (+15.1%). The segment drivers and cash flow follow.

Shionogi & Co.,Ltd.

Pharmaceutical


Quick View

MetricCurrentPriorYoY
Revenue¥3606.8B¥3336.0B+8.1%
Operating Income¥1487.4B¥1292.2B+15.1%
Profit Before Tax¥1912.7B¥1558.8B+22.7%
Net Income¥1582.1B¥1333.4B+18.7%
ROE10.4%9.8%-

Executive Summary

Performance Drivers

Segment Analysis

Key Metrics

Cash Flow Analysis

Earnings Quality

Guidance Update

Shareholder Returns

Catalysts

Industry Benchmark (Reference - Proprietary Data)

Risk Factors

Key Takeaways from Earnings


**